Mike Khouw joins 'Fast Money' to talk the options trade around Hims. Federal judge blocks largest supermarket merger in ...

Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these ...

Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS ...

For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the ...

Eli Lily continues to dominate the weight loss market, willing to crush any competitor that threatens its dominance. One such ...

Hims & Hers Health is financially strong with minimal debt and a dominant market share. Find out what makes HIMS stock a ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Hims & Hers Health, Inc.

The partnership between Ro and Eli Lilly (LLY) to streamline access to Lilly’s GLP-1 Zepbound single-dose vials for Ro patients with obesity is ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.87 which represents a decrease of $-1.76 or -5.39% from the prior close of $32.63. The stock opened at $32.25 and touched a low ...

BofA analyst Allen Lutz notes Ro Health, a direct competitor to Hims & Hers (HIMS), announced that the company is working with Eli Lilly ...

The digital health industry has experienced impressive growth, driven by rising healthcare demands, digitalization, and ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...